Optimising linezolid use for drug-resistant tuberculosis in South Africa: the effects of linezolid exposure on toxicity, treatment response, and linezolid resistance.
TMA2015CDF1018
EDCTP2
Career Development Fellowship (CDF)
1. Develop a population PK model of linezolid in South African patients with DR-TB. 2. Determine the effects of linezolid exposure on toxicity, treatment response, and linezolid resistance in South African patients with MDR and XDR- or pre-XDR-TB. 3. Define the relationships between linezolid PK parameters, functional mitochondrial activity, and clinical toxicity, and explore the association of SNPs in mtDNA with the risk of linezolid toxicity in this population
Prospective observational cohort study
Department | Institution | Country |
---|---|---|
Wellcome Centre for Infectious Diseases Research in Africa | University of Cape Town (UCT) | South Africa |